Asia Pacific Neurostimulation Devices Market, By Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others), By Application, By Country, Competition, Forecast & Opportunities, 2028

Asia Pacific neurostimulation devices market is expected to grow at a significant rate during the forecast period. The factors driving the growth of the market are increasing incidence of neurological disorders such as epilepsy, migraine, and others, along with extensive technological advancements. For instance, in 2019, in India, as per the Neurology India’s data, the common neurological disorders are stroke with 37.9%, followed by headache disorder with 17.5%, epilepsy with 11.3% and cerebral palsy with 5.7%. In addition, increasing geriatric population is also one of the main factors as they are more susceptible to neurological disorders such as Parkinson’s disease, Alzheimer’s diseases and others. Furthermore, the ongoing research and development activities to use neurostimulators for treating various conditions such as asthma, obsessive-compulsive disorders, and interstitial cystitis are anticipated to strengthen the growth of the market in upcoming years. According to the World Health Organization (WHO), 7.5% of Indians live with depression.

The Asia Pacific neurostimulation devices market is segmented into device type, application, company, and country. Based on device type, the market is categorized into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. Out of which, the spinal cord stimulators segment dominated the market in 2022 and is expected to maintain its dominance during the forecast period. This is attributed to high growth in number of product approvals, and rising demand for treating neuropathic pain and spinal injuries. Based on country, China is expected to dominate the market during the forecast period. This is due to surge in research and development activity, and use of integrated internal neurostimulation device in proteomic, genomic and clinical diagnostics, coupled with the growing demand for advanced neurostimulation devices in the treatment of chronic pain management.

Major players operating in the Asia Pacific neurostimulation devices market include Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, Nevro Corporation, Neuronetics Inc, NeuroSigma, Inc., Synapse Biomedical Inc. and others. The key market players are adopting some competitive strategies such as technological developments, mergers & acquisitions, partnership, collaborations, agreements in order to expand their geographic reach and to increase their customer bases.

Objective of the Study:

• To analyze and estimate the market size of Asia Pacific neurostimulation devices market from 2018 to 2021.
• To estimate and forecast the market size of Asia Pacific neurostimulation devices market from 2022 to 2028 and growth rate until 2028.
• To classify and forecast Asia Pacific neurostimulation devices market based on device type, application, company and country-wise distribution.
• To identify dominant region or segment in the Asia Pacific neurostimulation devices market.
• To identify drivers and challenges for Asia Pacific neurostimulation devices market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Asia Pacific neurostimulation devices market.
• To conduct pricing analysis for Asia Pacific neurostimulation devices market.
• To identify and analyze the profile of leading players operating in Asia Pacific neurostimulation devices market.
• To identify key sustainable strategies adopted by market players in Asia Pacific neurostimulation devices market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers across the region. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers which could not be identified due to the limitations of secondary research. The publisher analyzed the manufacturers and presence of all major players across the region.

The publisher calculated the market size of Asia Pacific neurostimulation devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

• Neurostimulation devices manufacturers, suppliers and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to neurostimulation devices
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Asia Pacific neurostimulation devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Asia Pacific Neurostimulation Devices Market, By Device Type:

• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Others

Asia Pacific Neurostimulation Devices Market, By Application:

• Pain Management
• Hearing Loss
• Urinary Incontinence
• Parkinson's Disease
• Epilepsy
• Others

Asia Pacific Neurostimulation Devices Market, By Country:

• China
• India
• Japan
• South Korea
• Australia
• Singapore
• Malaysia
• Vietnam
• Thailand
• Indonesia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Asia Pacific neurostimulation devices market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.